142 related articles for article (PubMed ID: 15694659)
1. Targeting senescence pathways to reverse drug resistance in cancer.
Rebbaa A
Cancer Lett; 2005 Feb; 219(1):1-13. PubMed ID: 15694659
[TBL] [Abstract][Full Text] [Related]
2. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
3. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
[TBL] [Abstract][Full Text] [Related]
4. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.
Gewirtz DA; Holt SE; Elmore LW
Biochem Pharmacol; 2008 Oct; 76(8):947-57. PubMed ID: 18657518
[TBL] [Abstract][Full Text] [Related]
5. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence.
Byun HO; Han NK; Lee HJ; Kim KB; Ko YG; Yoon G; Lee YS; Hong SI; Lee JS
Cancer Res; 2009 Jun; 69(11):4638-47. PubMed ID: 19487283
[TBL] [Abstract][Full Text] [Related]
7. Prospective strategies to enforce selectively cell death in cancer cells.
Blagosklonny MV
Oncogene; 2004 Apr; 23(16):2967-75. PubMed ID: 15077157
[TBL] [Abstract][Full Text] [Related]
8. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
[TBL] [Abstract][Full Text] [Related]
9. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
10. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.
Park H; Aiyar SE; Fan P; Wang J; Yue W; Okouneva T; Cox C; Jordan MA; Demers L; Cho H; Kim S; Song RX; Santen RJ
Cancer Res; 2007 Jun; 67(12):5717-26. PubMed ID: 17575138
[TBL] [Abstract][Full Text] [Related]
11. [Research advance on role of tumor microenvironment in mediating acquired drug resistance].
Ma XL; Xing H; Ma D
Ai Zheng; 2007 Aug; 26(8):923-6. PubMed ID: 17697561
[TBL] [Abstract][Full Text] [Related]
12. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Katsman A; Umezawa K; Bonavida B
Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602
[TBL] [Abstract][Full Text] [Related]
13. E2F-1 is a critical modulator of cellular senescence in human cancer.
Park C; Lee I; Kang WK
Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of nitric oxide in cancer.
Bonavida B; Khineche S; Huerta-Yepez S; Garbán H
Drug Resist Updat; 2006 Jun; 9(3):157-73. PubMed ID: 16822706
[TBL] [Abstract][Full Text] [Related]
15. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells.
Chang UM; Li CH; Lin LI; Huang CP; Kan LS; Lin SB
Life Sci; 2006 Aug; 79(12):1129-39. PubMed ID: 16635496
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells.
Lee J; Lee I; Park C; Kang WK
Biochem Biophys Res Commun; 2006 Jan; 339(3):748-54. PubMed ID: 16316623
[TBL] [Abstract][Full Text] [Related]
17. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY
Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280
[TBL] [Abstract][Full Text] [Related]
18. Resistance mechanisms in human lung cancer.
Mattern J; Volm M
Invasion Metastasis; 1995; 15(3-4):81-94. PubMed ID: 8621273
[TBL] [Abstract][Full Text] [Related]
19. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
20. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
